Altimmune Stock Price on October 8, 2024
ALT Stock | USD 8.25 0.07 0.86% |
Below is the normalized historical share price chart for Altimmune extending back to October 06, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Altimmune stands at 8.25, as last reported on the 23rd of December, with the highest price reaching 8.75 and the lowest price hitting 8.18 during the day.
If you're considering investing in Altimmune Stock, it is important to understand the factors that can impact its price. Altimmune appears to be slightly risky, given 3 months investment horizon. Altimmune secures Sharpe Ratio (or Efficiency) of 0.0663, which signifies that the company had a 0.0663% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Altimmune, which you can use to evaluate the volatility of the firm. Please makes use of Altimmune's Risk Adjusted Performance of 0.0477, downside deviation of 4.57, and Mean Deviation of 3.81 to double-check if our risk estimates are consistent with your expectations.
At this time, Altimmune's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 55.9 M in 2024, whereas Capital Stock is likely to drop 4,065 in 2024. . At this time, Altimmune's Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 3.24 in 2024, despite the fact that Price To Free Cash Flows Ratio is likely to grow to (7.50). Altimmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of October 2005 | 200 Day MA 7.427 | 50 Day MA 7.8803 | Beta 0.072 |
Altimmune |
Sharpe Ratio = 0.0663
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ALT | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.65 actual daily | 50 50% of assets are less volatile |
Expected Return
0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Altimmune is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Altimmune by adding it to a well-diversified portfolio.
Price Book 4.4074 | Enterprise Value Ebitda (4.20) | Price Sales 11.3 K | Shares Float 70.6 M | Wall Street Target Price 22.8571 |
Related Headline
Viking Therapeutics Headline on 8th of October 2024
Filed transaction by Viking Therapeutics Director, Officer President Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Altimmune Valuation on October 8, 2024
It is possible to determine the worth of Altimmune on a given historical date. On October 8, 2024 Altimmune was worth 6.09 at the beginning of the trading date compared to the closed value of 6.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Altimmune stock. Still, in general, we apply an absolute valuation method to find Altimmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Altimmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Altimmune's related companies.
Open | High | Low | Close | Volume | |
6.27 | 6.27 | 6.04 | 6.10 | 1,392,694 | |
10/08/2024 | 6.09 | 6.50 | 6.05 | 6.24 | 1,630,786 |
6.25 | 6.30 | 6.08 | 6.11 | 1,202,492 |
Backtest Altimmune | | | Altimmune History | | | Altimmune Valuation | Previous | Next |
Altimmune Trading Date Momentum on October 8, 2024
On October 09 2024 Altimmune was traded for 6.11 at the closing time. Highest Altimmune's price during the trading hours was 6.30 and the lowest price during the day was 6.08 . The net volume was 1.2 M. The overall trading history on the 9th of October contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 2.08% . The overall trading delta to current price is 8.81% . |
Altimmune Fundamentals Correlations and Trends
By evaluating Altimmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Altimmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Altimmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Altimmune Stock history
Altimmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Altimmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Altimmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Altimmune stock prices may prove useful in developing a viable investing in Altimmune
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 53.2 M | 55.9 M | |
Net Loss | -76.2 M | -72.4 M |
Altimmune Quarterly Net Working Capital |
|
Altimmune Stock Technical Analysis
Altimmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Altimmune Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Altimmune cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Altimmune December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Altimmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Altimmune shares will generate the highest return on investment. By undertsting and applying Altimmune stock market strength indicators, traders can identify Altimmune entry and exit signals to maximize returns
Altimmune Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Altimmune's price direction in advance. Along with the technical and fundamental analysis of Altimmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Altimmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0477 | |||
Jensen Alpha | 0.2496 | |||
Total Risk Alpha | 0.1117 | |||
Sortino Ratio | 0.0546 | |||
Treynor Ratio | 0.2772 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.